Regional dealmakers remain cautious about the prospects of an M&A recovery in Central and Eastern Europe (CEE). Nonetheless, in spite of fears surrounding a second wave of the pandemic, activity is reigniting in selected sectors, albeit under "new normal" conditions.
Watch Mergermarket’s Virtual Event on the M&A market outlook in Benelux in partnership with Datasite here.
Watch Mergermarket’s Virtual Event on the M&A market outlook in the CEE region here.
Watch Mergermarket’s Virtual Event on the Nordic market outlook and the impact of Covid-19 here.
No sector is closer than healthcare to the front-lines of the covid-19 pandemic.
Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A.
In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.
US asset and wealth management M&A saw a significant uptick before the coronavirus pandemic, fueled in part by aging registered investment advisors looking to sell at high valuations amid a booming stock market. While current volatility has put the brakes on activity, some deals are still getting done and the longer term prospects look healthy, notably driven by strong interest from private equity. Raymond James’ Liz and Peter Nesvold recently joined host Tom Cane to discuss the unfolding landscape for the sector. It's a time for companies to learn good habits in bad times and position themselves for future opportunities. According to Mergermarket data, Raymond James has been one of the most active investment banks in the field, with recent deals including advising Stratos Wealth Holdings on a strategic minority investment from Emigrant Partners.
The German economy is set to shrink by 10% in the three months to June as a result of the COVID-19 pandemic, but the DACH region is yet to see the effect of the pandemic on M&A value following several large transactions announced prior to the outbreak.
The CEE region saw a healthy level of dealmaking prior to the outbreak of coronavirus, but saw a fall in March as M&A across Europe began to slow. The region saw a clear decline by value, although fared better than other parts of Europe, while the deal count fell to its lowest point in several years.
Thorsten Louie Pedersen
Research Analyst, Mergermarket
As uncertainty surrounding the coronavirus pandemic began to hit corporates, the Nordic region fell short in attracting sizable deals in 1Q20 but instead witnessed a growing focus on start-ups and medium enterprises, a trend that is likely to continue.
Lucinda Guthrie
Executive Editor, Transactions Division, Acuris
Watch Mergermarket's webinar on UK M&A and the impact of COVID-19 here.
Global dealmaking has been brought to a standstill in the past few weeks and activity is likely to remain subdued for the coming months, according the Mergermarket's Q1 global M&A trend report.
Bill Curtin, Hogan Lovell’s global head of mergers and acquisitions, recently joined Mergermarket managing editor Tom Cane to discuss the impact of COVID-19 on M&A activity both in the immediate future and on the longer term horizon. What are companies and advisors doing now to get through this unprecedented challenge? Where will opportunities emerge and who is best placed to capitalize on them?
No more items to load
Load more
